Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in japan

HIGHLIGHTS

• who: Hiromi Matsumoto from the database in JapanCity University have published the article: Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan, in the Journal: Scientific Reports Scientific Reports
• what: Regional differences exist in the propensity to prescribe EGFR-TKIs for lung cancer.

SUMMARY

Number of lung cancer patients prescribed EGFR‑TKIs in each prefecture in Japan. There was no correlation between the number of EGFR tests per lung cancer patient and SCR (r=0.007, p=0.96 . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.